Varian ups market forecast

Article

Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26%

Other companies may be struggling to meet expectations for financial performance, but not Varian Medical Systems. On April 8, the company said its earnings for 2Q 2003 would rise 35% to 40% over the year-ago quarter. Previously, the company estimated 26% growth for the quarter. The better-than-expected earnings reflect a recovery much stronger than was anticipated in the x-ray products business, according to Varian. The company is also reporting continued strength in its oncology business. The strong quarter puts annual company earnings per diluted share for fiscal 2003 on track to grow by 29% to 31% over fiscal 2002 totals.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.